Developer of biopharmaceutical drugs designed to advance targeted therapies for cancer and other serious diseases. Coherent Biopharma is based in Suzhou, China. It has raised $130 million.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$130.0M
Last round
—
Cap table — not yet on record
Coherent Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
